MitoSynergy Introduces BioCopper1® - A Clinically Proven Nutraceutical Designed for Mitochondrial PerformanceScottsdale, AZ, March 24, 2026 (GLOBE NEWSWIRE) -- MitoSynergy, a science-driven wellness company focused on cellular and mitochondrial health, today announced the introduction of an improved BioCopper1®, a patented Copper (I) (Cu⁺) compound developed to address long-standing challenges associated with conventional copper supplementation.
